18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) - Combination of Icovamenib and GLP-1 Based Therapeutic Agents Improves Beta Cell Function and Insulin Secretion
Mar 20, 2025 at 4:10 PM EDT
Supporting Materials
Scroll to top
